Antitumor efficacy and safety of unedited autologous CD5.CAR T cells in relapsed/refractory mature T-cell lymphomas. Hill LC, Rouce RH, Wu MJ, Wang T, et al. Blood 2024;143:1231-1241.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hill LC, Rouce RH, Wu MJ, Wang T, et al. Antitumor efficacy and safety of unedited autologous CD5.CAR T cells in relapsed/refractory mature T-cell lymphomas. Blood 2024;143:1231-1241.
PMID: 38145560